Initial failure site according to primary treatment with or without para-aortic lymphadenectomy in endometrial cancer
Authors:
- 1 May 2011
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 121 (2) , 314-318
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysisThe Lancet, 2010
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2009
- Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?Gynecologic Oncology, 2008
- Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical stagingGynecologic Oncology, 2008
- Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility studyAmerican Journal of Obstetrics and Gynecology, 2004
- Sentinel lymph node detection in patients with endometrial cancerGynecologic Oncology, 2004
- Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomasCancer Letters, 2002
- Indispensability of Pelvic and Paraaortic Lymphadenectomy in Endometrial CancersGynecologic Oncology, 1997
- Intraabdominal Lymphatic Mapping to Direct Selective Pelvic and Paraaortic Lymphadenectomy in Women with High- Risk Endometrial Cancer: Results of a Pilot StudyGynecologic Oncology, 1996